ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GKOS Glaukos Corporation

109.29
1.85 (1.72%)
Last Updated: 11:50:11
Delayed by 15 minutes

Period:

Draw Mode:

Volume 83,256
Bid Price
Ask Price
News -
Day High 109.6225

Low
54.3801

52 Week Range

High
113.97

Day Low 107.28
Share Name Share Symbol Market Stock Type
Glaukos Corporation GKOS NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
1.85 1.72% 109.29 11:50:11
Open Price Low Price High Price Close Price Previous Close
108.09 107.28 109.6225 107.44
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,416 83,256 US$ 108.84 US$ 9,061,351 - 54.3801 - 113.97
Last Trade Type Quantity Price Currency
11:50:04 1 US$ 109.3436 USD

Glaukos Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.41B 49.47M - 314.71M -134.66M -2.72 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Glaukos News

Date Time Source News Article
5/20/202406:00Edgar (US Regulatory)Form 8-K - Current report
5/16/202418:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/15/202414:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/14/202415:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/14/202415:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/10/202416:00Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/10/202415:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/08/202416:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/08/202416:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/06/202416:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/06/202416:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/06/202415:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No GKOS Message Board. Create One! See More Posts on GKOS Message Board See More Message Board Posts

Historical GKOS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week110.84110.84106.13108.63345,222-1.55-1.40%
1 Month100.28113.9795.39105.75448,8379.018.98%
3 Months88.59113.9783.9096.63483,70820.7023.37%
6 Months63.09113.9759.2288.12663,92046.2073.23%
1 Year57.89113.9754.380180.20584,71951.4088.79%
3 Years75.36113.9733.3362.22521,46733.9345.02%
5 Years64.80113.9723.3159.85534,20844.4968.66%

Glaukos Description

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

Your Recent History

Delayed Upgrade Clock